title: Role of conservative (palliative) care-only in the management of advanced malignant pleural mesothelioma.
abstract: Despite new aggressive therapeutical options for advanced malignant pleural mesothelioma (MPM), benefits to survival remain limited. Moreover, deleterious effects of high-dose chemotherapy and aggressive surgery are well-known. Outcomes of untreated patients are usually not reported, and whether a treatment can be delayed or avoided is still an open question. We discuss here two clinical cases and with conservative (palliative) management alone for advanced MPM [corrected].
authors.affiliation: Department of Radiation Oncology, Gustave Roussy Institute, Paris XI University, Villejuif, France.
authors.forename: Antonin
authors.initials: A
authors.lastname: Levy
authors.forename: Avi
authors.initials: A
authors.lastname: Assouline
authors.forename: Sofia
authors.initials: S
authors.lastname: Rivera
authors.forename: Cyrus
authors.initials: C
authors.lastname: Chargari
authors.forename: Patricia
authors.initials: P
authors.lastname: Tai
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage; D001932:Brain Neoplasms / Q000532:radiotherapy / Q000556:secondary; D005260:Female; D006801:Humans; D008297:Male; D008654:Mesothelioma / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy*; D008875:Middle Aged; D010166:Palliative Care / Q000379:methods*; D010997:Pleural Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy*